Cataract surgery with implantation of a high-add intraocular lens LENTIS® MAX LS-313 MF80 in end-stage, age-related macular degeneration: A case report of magnifying surgery.

Andreas F BorkensteinEva-Maria Borkenstein

Published in: Clinical case reports (2018)

A new treatment option for cataracts and advanced ARMD: the simultaneous intravitreal injection of anti-vascular endothelial growth factor and implantation of a high-add IOL. We believe major opportunities arise from a new subcategory in cataract surgery-called magnifying surgery (MAGS). Our case proves the potential of this brand-new technology.

Keyphrases

cataract surgery
vascular endothelial growth factor
age related macular degeneration
minimally invasive
coronary artery bypass
endothelial cells
surgical site infection
coronary artery disease
diabetic retinopathy
climate change
combination therapy
optical coherence tomography